By Colin Kellaher
Merck & Co. plans to invest $895 million to expand its animal-health operations in De Soto, Kan.
Merck on Thursday said the move includes an $860 million investment in its existing biologics manufacturing facility, along with a $35 million investment in its research-and-development laboratories.
The Rahway, N.J., drug maker said the 200,000-square-foot manufacturing facility project will expand filling and freeze dryer capacity for large molecule vaccines and biologic products for its Merck Animal Health unit, which accounted for roughly 10% of the company's first-quarter sales of more than $15.5 billion.
Merck said site preparation and facility design will start immediately, creating 2,500 construction jobs, with commercial manufacturing slated to begin in 2030, creating more than 200 full-time roles.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 08, 2025 09:17 ET (13:17 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。